Livzon Pharmaceutical Group Inc. announced that the board of directors held its 28th meeting of the 11th session on 10 November 2025. During this meeting, the proposal to nominate Ms. Wang Zhiyao as an independent non-executive director was approved, pending final approval at an upcoming shareholders’ general meeting. The term of office would commence from the date of approval and conclude upon the expiry of the 11th session of the board.

According to the announcement, Ms. Wang recently attended the latest pre-appointment training for independent directors and obtained the certificate recognized by the Shenzhen Stock Exchange. The exchange has reviewed her qualifications and independence without raising any objections. The final appointment remains subject to the decision of the shareholders’ general meeting.